Stockscreener 앱 받기
69.15
0.21%
0.08
전일 마감가:
$69.23
열려 있는:
$69.17
하루 거래량:
1.77M
Relative Volume:
0.21
시가총액:
$277.97B
수익:
$42.09B
순이익/손실:
$14.65B
주가수익비율:
21.06
EPS:
3.2833
순현금흐름:
$10.11B
1주 성능:
+10.79%
1개월 성능:
+10.92%
6개월 성능:
-37.00%
1년 성능:
-43.62%
1일 변동 폭
$68.89
$69.76
1주일 범위
$64.16
$69.86
52주 변동 폭
$57.00
$148.15
노보 노디스크 Stock (NVO) Company Profile
NVO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NVO
Novo Nordisk Adr
|
69.24 | 277.97B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
LLY
Lilly Eli Co
|
825.59 | 739.75B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
154.78 | 370.90B | 89.33B | 21.81B | 18.57B | 8.99 |
|
ABBV
Abbvie Inc
|
196.16 | 340.25B | 57.37B | 4.20B | 17.83B | 2.35 |
|
NVS
Novartis Ag Adr
|
113.40 | 222.45B | 53.22B | 12.86B | 14.85B | 6.39 |
노보 노디스크 Stock (NVO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-17 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2025-03-13 | 업그레이드 | Kepler | Hold → Buy |
| 2025-03-03 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-02-12 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-01-06 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-04-12 | 개시 | BMO Capital Markets | Outperform |
| 2024-01-23 | 개시 | Morgan Stanley | Overweight |
| 2024-01-16 | 재개 | UBS | Neutral |
| 2023-12-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-10-02 | 개시 | Argus | Buy |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2022-07-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-28 | 다운그레이드 | UBS | Neutral → Sell |
| 2022-06-27 | 업그레이드 | Exane BNP Paribas | Underperform → Neutral |
| 2022-06-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-05-31 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-04-25 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2022-04-12 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2022-03-16 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-01-25 | 다운그레이드 | Liberum | Hold → Sell |
| 2021-12-20 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-12-17 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-01-20 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2021-01-15 | 개시 | Deutsche Bank | Buy |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-07-06 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-05-11 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-05-04 | 개시 | Cowen | Market Perform |
| 2020-03-16 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-01-03 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-11-18 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2019-09-17 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-08-30 | 다운그레이드 | Jefferies | Hold → Underperform |
| 2019-06-20 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-06-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-04-29 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-01-29 | 개시 | Exane BNP Paribas | Outperform |
| 2018-12-11 | 재개 | Jefferies | Hold |
| 2018-10-09 | 개시 | Guggenheim | Buy |
| 2017-12-29 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2017-12-06 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2017-12-01 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-09-25 | 다운그레이드 | Exane BNP Paribas | Outperform → Neutral |
| 2017-09-06 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
모두보기
노보 노디스크 주식(NVO)의 최신 뉴스
3 No-Brainer Stocks to Buy in May - The Motley Fool
Novo Nordisk Stock Price Today | NYSE: NVO Live - Investing.com
European ADRs Show Strength With Genfit And Novo Nordisk Leading Gains - Finimize
Novo Nordisk ADR [NVO] Revenue clocked in at $42.09 billion, down -27.20% YTD: What’s Next? - dbtnews.com
Novo Nordisk ADR (NVO) Stock: A Year of Market Fluctuations - investchronicle.com
Novo Nordisk ADR [NVO] Investment Appeal on the Rise - knoxdaily.com
Press Release Distribution & PR Platform - ACCESS Newswire
Novo Nordisk ADR (NYSE:NVO)’s 12-Month Price Target Currently Stands At 160 - Marketing Sentinel
Stocks of Novo Nordisk ADR (NVO) are poised to climb above their peers - Sete News
An Analysis of E-Home Household Service Holdings Ltd (EJH)’s Potential Price Growth - knoxdaily.com
Taking a Closer Look At Novo Nordisk ADR (NVO) Following Its Recent Trade - knoxdaily.com
3 ‘buy the dip’ candidates with wide moats - Morningstar
Recent Insider Activity Could Benefit Vodafone Group plc ADR (VOD) - knoxdaily.com
Balance Sheet Breakdown: Novo Nordisk ADR (NVO)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
Novo Nordisk ADR (NVO) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com
European ADRs Rise As Prudential And BP Lead The Pack - Finimize
NVO Stock Quote Price and Forecast - CNN
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading - marketscreener.com
Is Novo Nordisk Stock a Buy After its Collapse? - Morningstar
Eli Lilly and Novo Nordisk: Obesity Drug Coverage in Medicare Not a Straight Path - Morningstar
Novo Nordisk ADR: Analyzing NVO Stock Trends - investchronicle.com
Novo Nordisk ADR’s: Contrasting Stock Performances in a Volatile Market - investchronicle.com
Is Novo Nordisk (NVO) the Best ADR Stock to Buy According to Hedge Funds? - Insider Monkey
Novo Nordisk’s $2B deal for obesity drug a strategic game-changer for US pharmaceutical market - Yahoo Finance
Why Novo Nordisk Stock Dipped on Thursday - Yahoo Finance
What a Covid-19 vaccine means for investors - Morningstar
Novo Nordis Share Price | NYSE: NVO Stock - Investing.com UK
노보 노디스크 (NVO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.28%
자본화:
|
볼륨(24시간):